Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Respiratory Syncytial Virus Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Post-approval studies (Phase 4)Study completedNCT02571517
What this trial is testing

Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis

Who this might be right for
Bronchiolitis, Viral
Fundació Sant Joan de Déu 94
Early research (Phase 1)Study completedNCT05585632
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Who this might be right for
SARS-CoV-2InfluenzaRSV
ModernaTX, Inc. 392
Not applicableStudy completedNCT05070975
What this trial is testing

Severity of RSV Infections in Twins

Who this might be right for
RSV InfectionBronchiolitis
Hospices Civils de Lyon 94
Not applicableNot Yet RecruitingNCT07417657
What this trial is testing

Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants

Who this might be right for
Respiratory Syncytial Virus InfectionBronchiolitisViral Lower Respiratory Tract Infection (LRTI)
Phuc Huu Phan 250
Not applicableActive Not RecruitingNCT03756766
What this trial is testing

Understanding RSV: Severe Disease and the Long Term Consequences

Who this might be right for
Respiratory Syncytial Virus (RSV)
University of Oxford 315
Not applicableStudy completedNCT03095495
What this trial is testing

High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue

Who this might be right for
BronchiolitisRespiratory Syncytial Virus (RSV)
Hamad Medical Corporation 28
Large-scale testing (Phase 3)Study completedNCT02911935
What this trial is testing

Azithromycin to Prevent Wheezing Following Severe RSV Bronchiolitis-II

Who this might be right for
Respiratory Syncytial Virus, Bronchiolitis
Washington University School of Medicine 200
Not applicableActive Not RecruitingNCT06851806
What this trial is testing

Study of Palivizumab in Children With High Risk of Severe Respiratory Syncytial Virus (RSV) Disease

Who this might be right for
Respiratory Syncytial Virus (RSV)
AstraZeneca 21
Large-scale testing (Phase 3)Study completedNCT01006629
What this trial is testing

Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children

Who this might be right for
Respiratory Syncytial Virus InfectionPremature BirthBronchopulmonary Dysplasia+1 more
Abbott 100
Testing effectiveness (Phase 2)Looking for participantsNCT07214571
What this trial is testing

S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease

Who this might be right for
Respiratory Syncytial Virus Infections
Shionogi 192
Large-scale testing (Phase 3)Study completedNCT02968173
What this trial is testing

Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 50
Large-scale testing (Phase 3)Study completedNCT05070546
What this trial is testing

An Ad26.RSV. preF-based Vaccine in Adults Aged 18 to 59 Years, Including Adults at High Risk for Severe RSV Infection

Who this might be right for
Respiratory Syncytial Virus Infection Prevention
Janssen Vaccines & Prevention B.V. 1,124
Large-scale testing (Phase 3)Study completedNCT04938830
What this trial is testing

Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)

Who this might be right for
RSV Infection
Merck Sharp & Dohme LLC 1,003